Zgurskaya Helen I, Löpez Cesar A, Gnanakaran S
Department of Chemistry and Biochemistry, University of Oklahoma, 101 Stephenson Parkway, Norman, Oklahoma 73019, United States.
Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, United States.
ACS Infect Dis. 2015;1(11):512-522. doi: 10.1021/acsinfecdis.5b00097.
Gram-negative bacteria are intrinsically resistant to many antibiotics. Species that have acquired multidrug resistance and cause infections that are effectively untreatable present a serious threat to public health. The problem is broadly recognized and tackled at both the fundamental and applied levels. This paper summarizes current advances in understanding the molecular bases of the low permeability barrier of Gram-negative pathogens, which is the major obstacle in discovery and development of antibiotics effective against such pathogens. Gaps in knowledge and specific strategies to break this barrier and to achieve potent activities against difficult Gram-negative bacteria are also discussed.
革兰氏阴性菌对许多抗生素具有内在抗性。那些获得了多重耐药性并导致有效治疗的感染的物种对公众健康构成了严重威胁。这个问题在基础和应用层面都得到了广泛的认识和解决。本文总结了目前在理解革兰氏阴性病原体低通透性屏障的分子基础方面的进展,这是发现和开发有效对抗此类病原体的抗生素的主要障碍。还讨论了知识空白以及突破这一屏障并实现对难对付的革兰氏阴性菌产生强效活性的具体策略。